Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

Abstract

Get full access to this article

View all access options for this article.

References

Salzer

Nyström

Hallmans

. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler. Epub ahead of print 2 April 2013.

Levin

Munger

Rubertone

. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496–2500.

Munger

Levin

Hollis

. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832–2838.

Salzer

Hallmans

Nyström

. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012; 79: 2140–2145.

Smolders

Peelen

Thewissen

. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PloS One 2010; 5: e15235.

Farrell

Antony

Wall

. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009; 73: 32–38.

Knippenberg

Smolders

Thewissen

. Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Mult Scler 2011; 17: 1418–1423.

Hewison

. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011; 7: 337–345.

Beard

Bearden

Striker

. Vitamin D and the anti-viral state. J Clin Virol 2011; 50: 194–200.

10.

Chen

Sims

Chen

. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179: 1634–1647.

11.

Zwart

Mehta

Ploutz-Snyder

. Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr virus reactivation. J Nutr 2011; 141: 692–697.

12.

Disanto

Pakpoor

Morahan

. Epstein-Barr virus, latitude and multiple sclerosis. Mult Scler 2013; 19: 362–365.